Evidence from a 37-center ICU trial in France shows IV propofol outperforms inhaled sevoflurane in moderate to severe ARDS:
🔻 Fewer ventilator-free days
🔻 Lower 90-day survival
🔻 Higher early mortality
🔗 JAMA: jamanetwork.com/journals/jam...
Evidence from a 37-center ICU trial in France shows IV propofol outperforms inhaled sevoflurane in moderate to severe ARDS:
🔻 Fewer ventilator-free days
🔻 Lower 90-day survival
🔻 Higher early mortality
🔗 JAMA: jamanetwork.com/journals/jam...
https://traffic.libsyn.com/criticalcarepractitioner/Tim_audio_for_podcast_final_2.mp3
https://traffic.libsyn.com/criticalcarepractitioner/Tim_audio_for_podcast_final_2.mp3
@aartisarwal about Chat GPT and large language models and how it will change things. Fascinating!
@CC_Symposium
#accs2024
@aartisarwal about Chat GPT and large language models and how it will change things. Fascinating!
@CC_Symposium
#accs2024
@CC_Symposium
#accs2024
@CC_Symposium
#accs2024
https://criticalcarepractitioner.podia.com/
https://criticalcarepractitioner.podia.com/
https://criticalcarepractitioner.podia.com/
https://criticalcarepractitioner.podia.com/
Livestream 2pm GMT 19th February on Facebook- 'The Critical Care Practitioner'
Livestream 2pm GMT 19th February on Facebook- 'The Critical Care Practitioner'